Evaluating a New Class of AKT/mTOR Activators for HIV Latency Reversing Activity Ex Vivo and In Vivo. - Gramatica A; Schwarzer R; Brantley W; Varco-Merth B; Sperber HS; Hull PA; Montano M; Migueles SA; Rosenthal D; Hogan LE; Johnson JR; Packard TA; et al. (Journal of virology, 2021)